ValiRx PLC - Signed Evaluation Agreement with Imperial College London

Dr Cathy Tralau-Stewart, CSO of Valirx discusses ValiRx's pipeline and the latest agreement signed with Imperial College London. This agreement enables ValiRx to evaluate research relating to novel therapeutic candidates for cancer treatment.

Dr Cathy Tralau-Stewart
Chief Scientific Officer

Company Events - VALIRX PLC